CAMP4 raises $100m to take lead RNA drugs into clinic
pharmaphorum
JULY 20, 2022
The Cambridge, Massachusetts biotech has discovered that areas of the non-coding parts of the human genome – referred to by its chief executive Josh Mandel-Brehm (pictured above) as the “dark side” of the genome – actually produce regRNAs that control the expression of the 2% that codes for proteins.
Let's personalize your content